These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 26362675

  • 1. Peripheral blood NK cells expressing HLA-G, IL-10 and TGF-β in healthy donors and breast cancer patients.
    Ostapchuk YO, Cetin EA, Perfilyeva YV, Yilmaz A, Skiba YA, Chirkin AP, Omarbaeva NA, Talaeva SG, Belyaev NN, Deniz G.
    Cell Immunol; 2015; 298(1-2):37-46. PubMed ID: 26362675
    [Abstract] [Full Text] [Related]

  • 2. Content of HLA-G(+) T Cells in the Peripheral Blood from Healthy Women and Breast Cancer Patients.
    Ostapchuk EO, Perfi L'eva YV, Talaeva ShZh, Omarbaeva NA, Belyaev NN.
    Bull Exp Biol Med; 2015 Sep; 159(5):649-51. PubMed ID: 26468020
    [Abstract] [Full Text] [Related]

  • 3. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
    Seo N, Tokura Y, Takigawa M, Egawa K.
    J Immunol; 1999 Jul 01; 163(1):242-9. PubMed ID: 10384122
    [Abstract] [Full Text] [Related]

  • 4. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
    Harthun NL, Weaver AM, Brinckerhoff LH, Deacon DH, Gonias SL, Slingluff CL.
    J Immunother; 1998 Mar 01; 21(2):85-94. PubMed ID: 9551359
    [Abstract] [Full Text] [Related]

  • 5. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT.
    J Clin Invest; 1993 Dec 01; 92(6):2569-76. PubMed ID: 7504687
    [Abstract] [Full Text] [Related]

  • 6. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta.
    Eriksson M, Meadows SK, Wira CR, Sentman CL.
    J Leukoc Biol; 2004 Sep 01; 76(3):667-75. PubMed ID: 15178706
    [Abstract] [Full Text] [Related]

  • 7. NK cytolysis is dependent on the proportion of HLA-G expression.
    Chen BG, Xu DP, Lin A, Yan WH.
    Hum Immunol; 2013 Mar 01; 74(3):286-9. PubMed ID: 23238216
    [Abstract] [Full Text] [Related]

  • 8. Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression.
    Yoon SJ, Heo DS, Kang SH, Lee KH, Kim WS, Kim GP, Lee JA, Lee KS, Bang YJ, Kim NK.
    Anticancer Res; 1998 Mar 01; 18(3A):1591-6. PubMed ID: 9673375
    [Abstract] [Full Text] [Related]

  • 9. Cytokine production by non-stimulated peripheral blood NK cells and lymphocytes in early-onset severe pre-eclampsia without HELLP.
    Bueno-Sánchez JC, Agudelo-Jaramillo B, Escobar-Aguilerae LF, Lopera A, Cadavid-Jaramillo AP, Chaouat G, Maldonado-Estrada JG.
    J Reprod Immunol; 2013 Apr 01; 97(2):223-31. PubMed ID: 23415844
    [Abstract] [Full Text] [Related]

  • 10. Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-beta1) in patients with gastric cancer.
    Szkaradkiewicz A, Karpiński TM, Drews M, Borejsza-Wysocki M, Majewski P, Andrzejewska E.
    J Biomed Biotechnol; 2010 Apr 01; 2010():901564. PubMed ID: 20445748
    [Abstract] [Full Text] [Related]

  • 11. β2-Microglobulin-free HLA-G activates natural killer cells by increasing cytotoxicity and proinflammatory cytokine production.
    Zhao L, Purandare B, Zhang J, Hantash BM.
    Hum Immunol; 2013 Apr 01; 74(4):417-24. PubMed ID: 23228393
    [Abstract] [Full Text] [Related]

  • 12. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3.
    Gray JD, Hirokawa M, Ohtsuka K, Horwitz DA.
    J Immunol; 1998 Mar 01; 160(5):2248-54. PubMed ID: 9498764
    [Abstract] [Full Text] [Related]

  • 13. Receptor modulation and functional activation of human CD34+ Lin- -derived immature NK cells in vitro by Mycobacterium bovis Bacillus Calmette-Guerin (BCG).
    Marras F, Bozzano F, Bentivoglio G, Ugolotti E, Biassoni R, Moretta L, De Maria A.
    Eur J Immunol; 2012 Sep 01; 42(9):2459-70. PubMed ID: 22736333
    [Abstract] [Full Text] [Related]

  • 14. Trogocytosis-based generation of suppressive NK cells.
    Caumartin J, Favier B, Daouya M, Guillard C, Moreau P, Carosella ED, LeMaoult J.
    EMBO J; 2007 Mar 07; 26(5):1423-33. PubMed ID: 17318190
    [Abstract] [Full Text] [Related]

  • 15. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG, Placke T, Salih HR.
    Cancer Res; 2009 Oct 01; 69(19):7775-83. PubMed ID: 19738039
    [Abstract] [Full Text] [Related]

  • 16. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
    Webb BJ, Bochan MR, Montel A, Padilla LM, Brahmi Z.
    Cell Immunol; 1994 Dec 01; 159(2):246-61. PubMed ID: 7994757
    [Abstract] [Full Text] [Related]

  • 17. HLA-G inhibition of NK-cell cytolytic function is uncoupled from tumor cell lipid raft reorganization.
    Baudhuin J, Lesport E, Sousa S, Migraine J, Vigneron J, Lemaoult J, Carosella ED, Mooney N, Favier B.
    Eur J Immunol; 2012 Mar 01; 42(3):700-9. PubMed ID: 22144141
    [Abstract] [Full Text] [Related]

  • 18. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
    Lin CY, Chuang TF, Liao KW, Huang YJ, Pai CC, Chu RM.
    Cancer Lett; 2008 Dec 18; 272(2):285-95. PubMed ID: 18760876
    [Abstract] [Full Text] [Related]

  • 19. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells.
    Saito S, Morii T, Enomoto M, Sakakura S, Nishikawa K, Narita N, Ichijo M.
    Cell Immunol; 1993 Dec 18; 152(2):605-13. PubMed ID: 7504983
    [Abstract] [Full Text] [Related]

  • 20. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
    Miller JS, Tessmer-Tuck J, Pierson BA, Weisdorf D, McGlave P, Blazar BR, Katsanis E, Verfaillie C, Lebkowski J, Radford J, Burns LJ.
    Biol Blood Marrow Transplant; 1997 Apr 18; 3(1):34-44. PubMed ID: 9209739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.